Scientists utilized the strategy of iterative gene pairing to construct a tumor-specific immune-related lincRNA pairs signature, which did not require specific expression levels, as an indicator of patient outcomes.
[Scientific Reports]
Sorry, but the selected Zotpress account can't be found.
